Intuitive Surgical is poised for a notable 17% sales growth driven by strong procedure volumes and the increasing installation of da Vinci systems. Analysts anticipate robust results, including Q2 revenue of $2.35 billion and normalized EPS of $1.93. For FY 2025, revenue is expected to reach $9.66 billion and EPS $7.83, reflecting overall growth despite challenges like foreign exchange and pricing pressures. Key areas of interest include procedure growth in the U.S., system placements, and advancements in AI technologies.
Intuitive Surgical is anticipated to achieve 17% sales growth, supported by increasing procedure volumes and an expanding number of da Vinci system installations through 2025.
Investment in advanced vision technology and integrating AI decision-support are critical focuses, with analysts seeking detailed timelines regarding commercial advancements.
Collection
[
|
...
]